Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Canagliflozin, Metformin | Vokanamet | Details | ||
| Nilotinib | Tasigna | Details | ||
| Denosumab | Prolia | Details | ||
| Salbutamol | Farcolin | Details | ||
| Rivastigmine | Rivaxel | Details | ||
| Etanercept | Enbrel | Details | ||
| Salbutamol | Butalin | Details | ||
| Clozapine | Leponex | Details | ||
| Eltrombopag | Revolade | Details | ||
| Panitumumab | Vectibix | Details |
